These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 22133787

  • 1. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation.
    Gonzalez-Vilchez F, Vazquez de Prada JA, Almenar L, Arizon Del Prado JM, Mirabet S, Diaz-Molina B, Delgado JF, Gomez-Bueno M, Paniagua MJ, Perez-Villa F, Roig E, Martínez-Dolz L, Brossa V, Lambert JL, Segovia J, Crespo-Leiro MG, Ruiz-Cano MJ.
    J Heart Lung Transplant; 2012 Mar; 31(3):288-95. PubMed ID: 22133787
    [Abstract] [Full Text] [Related]

  • 2. Temporal trends in the use of proliferation signal inhibitors in maintenance heart transplantation: a Spanish multicenter study.
    Gonzalez-Vilchez F, Almenar L, Arizón JM, Mirabet S, Delgado JF, Diez de Molina B, Gomez M, Paniagua MJ, Pérez-Villa F, Roig E, Vazquez de Prada JA.
    Transplant Proc; 2010 Oct; 42(8):2997-3000. PubMed ID: 20970592
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical recommendations for the use of everolimus in heart transplantation.
    Manito N, Delgado JF, Crespo-Leiro MG, González-Vílchez F, Almenar L, Arizón JM, Díaz B, Fernández-Yáñez J, Mirabet S, Palomo J, Rodríguez Lambert JL, Roig E, Segovia J.
    Transplant Rev (Orlando); 2010 Jul; 24(3):129-42. PubMed ID: 20619801
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.
    Rothenburger M, Teerling E, Bruch C, Lehmkuhl H, Suwelack B, Bara C, Wichter T, Hinder F, Schmid C, Stypmann J.
    J Heart Lung Transplant; 2007 Mar; 26(3):250-7. PubMed ID: 17346627
    [Abstract] [Full Text] [Related]

  • 11. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Bergh CH.
    Transplantation; 2010 Apr 15; 89(7):864-72. PubMed ID: 20061999
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sirolimus as an alternative to anticalcineurin therapy in heart transplantation: experience of a single center.
    Fernandez-Valls M, Gonzalez-Vilchez F, de Prada JA, Ruano J, Ruisanchez C, Martin-Duran R.
    Transplant Proc; 2005 Nov 15; 37(9):4021-3. PubMed ID: 16386615
    [Abstract] [Full Text] [Related]

  • 15. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
    de Fijter JW.
    Nephrol Dial Transplant; 2007 May 15; 22 Suppl 1():i23-6. PubMed ID: 17456615
    [Abstract] [Full Text] [Related]

  • 16. Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient--not all proliferation signal inhibitors are the same: a case report.
    De Simone P, Petruccelli S, Precisi A, Carrai P, Doria R, Menichetti F, Filipponi F.
    Transplant Proc; 2007 Dec 15; 39(10):3500-1. PubMed ID: 18089420
    [Abstract] [Full Text] [Related]

  • 17. Recovery of renal function in heart transplantation patients after conversion from a calcineurin inhibitor-based therapy to sirolimus.
    Ayub-Ferreira SM, Avila MS, Feitosa FS, Souza GE, Mangini S, Marcondes-Braga FG, Issa VS, Bacal F, Chizzola PR, Cruz FD, Bocchi EA.
    Transplant Proc; 2010 Mar 15; 42(2):542-4. PubMed ID: 20304188
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of sirolimus and everolimus in heart transplant patients: a retrospective analysis.
    Baur B, Oroszlan M, Hess O, Carrel T, Mohacsi P.
    Transplant Proc; 2011 Jun 15; 43(5):1853-61. PubMed ID: 21693289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.